Felodipine does not affect mortality in heart failure
Felodipine does not affect mortality in heart failure
In V-HeFT III, felodipine SR or placebo was randomly administered to 450 patients with chronic heart failure receiving optimal therapy with enalapril and diuretics. Mortality (13.8 versus 12.8 percent) did not differ significantly between the two groups.
Data from: Cohen JN, Ziesche S, Smith R, et al, for the Vasodilator-Heart Failure Trial (V-HeFT) Study Group, Circulation 1997; 96:856.
